Cargando…
Elevated FKBP52 expression indicates a poor outcome in patients with breast cancer
The 52-kDa FK506-binding protein (FKBP52), a regulator of steroid hormone receptor signaling, is potentially involved in a variety of hormone-dependent cancer types. The present study investigated the expression and clinical implications of FKBP52 in breast cancer. Immunohistochemistry was performed...
Autores principales: | Hong, Chaoqun, Li, Ting, Zhang, Fan, Wu, Xiao, Chen, Xipeng, Cui, Xiaojiang, Zhang, Guojun, Cui, Yukun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652253/ https://www.ncbi.nlm.nih.gov/pubmed/29113172 http://dx.doi.org/10.3892/ol.2017.6828 |
Ejemplares similares
-
FKBP52 and FKBP51 differentially regulate the stability of estrogen receptor in breast cancer
por: Habara, Makoto, et al.
Publicado: (2022) -
Biological Actions of the Hsp90-binding Immunophilins FKBP51 and FKBP52
por: Zgajnar, Nadia R., et al.
Publicado: (2019) -
FKBP14 overexpression contributes to osteosarcoma carcinogenesis and indicates poor survival outcome
por: Huang, Zhongming, et al.
Publicado: (2016) -
Expression of FKBP52 in the ovaries of PCOS rats
por: Song, Shiyan, et al.
Publicado: (2019) -
FKBP51 and FKBP52 regulate androgen receptor dimerization and proliferation in prostate cancer cells
por: Maeda, Keisuke, et al.
Publicado: (2021)